In line with these studies, TRIM24 was identified as an evolutionarily conserved negative regulator of wtp53, by promoting wtp53 ubiquitination and destruction via its RING-finger domain, from Drosophila to mammalian cells, and was suggested as a therapeutic target to restore p53 activity in cancer. Here, TP53 is linked to cancer.